Refractory generalized myasthenia gravis

Refractory generalized myasthenia gravis is a rare autoimmune disorder of the neuromuscular junction, characterized by fatigable muscle weakness. Patients initially only suffer ocular symptoms, but in most cases, the disease spreads beyond the eye muscles to more generalized involvement of bulbar, facial, neck, proximal limb and respiratory muscles.

Showing the single result

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price
C5 complement protein
Monoclonal Antibody
Soliris®
10 mg/mL
yes
4 mg
2-8°C/-80°C
04/2022
1.209,00 
view product
Max: 10
Min: 1
Step: 1

Not looking for Refractory generalized myasthenia gravis?

Search our therapeutic molecules product database

Evidentic Support
+49 (0) 30 959 99 8831

Let us know about your inquiry details and we’ll contact you shortly.